Emerging Diagnostic and Therapeutic Options for Meningioma
Over the past five years, multiple advances in diagnostic imaging, molecular stratification, and neurosurgical and radiotherapeutic approaches have changed the multi-disciplinary management of meningioma, the most common intracranial tumor.
Category
  • Central Nervous System
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Brain Metastases Radiotherapy While Mitigating Radionecrosis and Neurotoxicity in a Community Setting
There are many strategies for managing brain mets with radiotherapy.
Category
  • Central Nervous System
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Repeat Radiotherapy of the Brain and Spine: A Case-Based Review of Efficacy and Safety and How to Implement a Standardized Process
Radiotherapy or radiosurgery is the primary treatment for most patients with primary brain tumors and metastatic tumors of the brain and spine. With increasing overall survival for these patients, they are at an increasing risk of tumor recurrence within a previously irradiated field.
Category
  • Central Nervous System
  • Patient Safety
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Management of Radiation-Induced CNS Toxicities
Improvement in cancer therapies have increased the number of long-term survivors with brain and spine tumors. While radiation therapy remains one of the cornerstones of treatment modalities, it is associated with toxicities that can impact quality of life.
Category
  • Central Nervous System
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Gray Zone - Radionuclear ESCCalation: Local Therapy for Epidural Spinal Cord Compression in the Context of Peptide Receptor Radionuclide Therapy (PRRT)
The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.
Category
  • Central Nervous System
  • Radiobiology
  • SBRT
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $0.00
Updates and Challenging Cases in Pediatric Neuroblastoma and Wilms Tumor
Updates in the treatment of pediatric neuroblastoma and Wilms Tumor are presented, highlighting recent practice-changing publications and evolving study questions.
Category
  • Central Nervous System
  • Pediatric
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Gray Zone - Nerve Wracking: Approaches to Locally Advanced Skull Base Adenoid Cystic Carcinoma with Extensive Perineural Spread
The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.
Category
  • Central Nervous System
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $0.00
Integrating Radiation Therapy with Novel Immunotherapies in the Management of Brain Metastases and Leptomeningeal Disease
With improved systemic therapy, the management of brain metastasis has become increasingly important. A number of immunotherapies and targeted agents have shown blood brain barrier penetration with a potential role in the upfront management of brain metastases and leptomeningeal disease.
Category
  • Central Nervous System
  • Immunotherapy
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
ASTRO/SNO Joint Activity: Current Multidisciplinary Management of Molecularly Defined IDH Mutant Grade 2 - 3 Glioma - Who, What, When, Why and How?
The management of patients with grade 2 – 3 glioma has recently become even more complicated due to incorporation of molecular findings for pathologic diagnosis, changing criteria for who is considered high risk, and variability in the use and choice of chemotherapy with radiotherapy.
Category
  • Central Nervous System
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Potential Value of 68Ga-DOTATATE PET for Skull Base Meningioma Radiation Treatment Planning
This activity provides practitioners with the knowledge to use Dotatate PET for meningioma RT targeting.This activity is available from January 8, 2026, through 11:59 p.m. Eastern time on January 7, 2028.
Category
  • Central Nervous System
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00

Pages